Study of letrozole in postmenopausal patients with breast cancer (JBCRG M02)
Phase 2
- Conditions
- Postmenopausal patients with breast cancer
- Registration Number
- JPRN-UMIN000000563
- Lead Sponsor
- Japan Breast Cancer Research Group (JBCRG)
- Brief Summary
CR2, PR16, SD over 24 weeks 20, PD1
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Inflammatory breast cancer Lymphangitic lung metastasis Brain metastasis Diffuse liver metastasis Active double cancer Prior aromatase inhibitors within one year
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method